• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶血尿毒综合征的水化治疗。

Hydration in hemolytic uremic syndrome.

机构信息

Departamento de Urgencias, Hospital de Niños "Ricardo Gutiérrez" de Buenos Aires, Argentina.

Servicio de Nefrología, Hospital de Niños "Ricardo Gutiérrez" de Buenos Aires, Argentina.

出版信息

Arch Argent Pediatr. 2021 Feb;119(1):62-66. doi: 10.5546/aap.2021.eng.62.

DOI:10.5546/aap.2021.eng.62
PMID:33458983
Abstract

Diarrhea-associated hemolytic uremic syndrome is preceded by gastroenteritis due to Shiga toxin-producing Escherichia coli. Support measures are recommended, specifically, fluid restriction to avoid cardiopulmonary overload. However, in the prodromal period or with established hemolytic uremic syndrome, volume expansion with isotonic fluids is safe and effective, and reduces the need for dialysis, the length of hospital and intensive care stay, neurological events, and hyponatremia. Therefore, when nephrological monitoring is available and/or short-term access to a tertiary care hospital is guaranteed, it is suggested to hydrate patients with no signs of cardiopulmonary overload, regardless of their renal function, with initial volume expansion. Afterwards, if an adequate urine output is achieved, the patient should not be dialyzed (except if they have a medically intractable metabolic/electrolyte disorder) and hydration should be continued with an isotonic solution containing 5 % dextrose for adequate hydration and urine output.

摘要

腹泻相关性溶血尿毒综合征由产志贺毒素大肠埃希菌引起的肠胃炎引发。推荐支持治疗,具体来说,限制液体摄入以避免心肺过载。然而,在前驱期或已确诊溶血尿毒综合征的情况下,用等渗液进行容量扩张是安全有效的,可减少透析需求、住院和重症监护时间、神经事件和低钠血症的发生。因此,当具备肾脏科监测条件和/或能保证短期转至三级护理医院时,建议对无心肺过载迹象的患者进行补液,无论其肾功能如何,先进行初始容量扩张。之后,如果达到足够的尿量,患者不应进行透析(除非存在医学上无法处理的代谢/电解质紊乱),应继续用含 5%葡萄糖的等渗溶液进行补液,以保持充足的液体摄入和尿量。

相似文献

1
Hydration in hemolytic uremic syndrome.溶血尿毒综合征的水化治疗。
Arch Argent Pediatr. 2021 Feb;119(1):62-66. doi: 10.5546/aap.2021.eng.62.
2
Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.德国产志贺毒素大肠杆菌 O104:H4 疫情概况。
N Engl J Med. 2011 Nov 10;365(19):1771-80. doi: 10.1056/NEJMoa1106483. Epub 2011 Jun 22.
3
Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.大肠杆菌O157:H7感染期间的相对肾脏保护作用:与静脉补液扩容的关系
Pediatrics. 2005 Jun;115(6):e673-80. doi: 10.1542/peds.2004-2236.
4
Hemolytic uremic syndrome with simultaneous Shiga toxin producing Escherichia coli and complement abnormalities.伴有产志贺毒素大肠杆菌及补体异常的溶血尿毒综合征
BMC Pediatr. 2014 Nov 5;14:278. doi: 10.1186/1471-2431-14-278.
5
Volume Resuscitation and Progression to Organ Failure in Shiga Toxin-Producing Infection in Adults.成人产志贺毒素感染中的容量复苏与器官衰竭进展
Crit Care Explor. 2021 May 18;3(5):e0423. doi: 10.1097/CCE.0000000000000423. eCollection 2021 May.
6
Fluid restriction versus volume expansion in children with diarrhea-associated HUS: a retrospective observational study.腹泻相关性 HUS 患儿的液体限制与容量扩张:一项回顾性观察研究。
Pediatr Nephrol. 2021 Jan;36(1):103-109. doi: 10.1007/s00467-020-04673-6. Epub 2020 Jul 17.
7
Hyponatremia: a new predictor of mortality in patients with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.低钠血症:产志贺毒素大肠埃希菌溶血尿毒综合征患者死亡的新预测因子。
Pediatr Nephrol. 2018 Oct;33(10):1791-1798. doi: 10.1007/s00467-018-3991-6. Epub 2018 Jun 30.
8
Stratified therapy in Shiga toxin-producing Escherichia coli associated with hemolytic uremic syndrome.产志贺毒素大肠杆菌所致溶血尿毒综合征的分层治疗
Pediatr Int. 2020 Mar;62(3):305-306. doi: 10.1111/ped.14161.
9
Early Volume Expansion and Outcomes of Hemolytic Uremic Syndrome.早期容量扩张与溶血尿毒综合征的预后
Pediatrics. 2016 Jan;137(1). doi: 10.1542/peds.2015-2153. Epub 2015 Dec 7.
10
Clinical features of critically ill patients with Shiga toxin-induced hemolytic uremic syndrome.志贺毒素引起的溶血尿毒症综合征危重症患者的临床特征。
Crit Care Med. 2013 Jul;41(7):1702-10. doi: 10.1097/CCM.0b013e31828a24a8.

引用本文的文献

1
Neurological Manifestations of Hemolytic Uremic Syndrome: A Comprehensive Review.溶血尿毒综合征的神经学表现:全面综述
Brain Sci. 2025 Jul 4;15(7):717. doi: 10.3390/brainsci15070717.
2
Pericardial effusion in pediatric Shiga toxin-producing E. coli hemolytic uremic syndrome: a French multicentre study.产志贺毒素大肠杆菌溶血尿毒综合征患儿的心包积液:一项法国多中心研究
Pediatr Nephrol. 2025 Jul 22. doi: 10.1007/s00467-025-06877-0.
3
Characteristics of hemolytic uremic syndrome in patients from a pediatric hospital in Peru, 2010-2020.
2010-2020 年秘鲁一家儿童医院溶血尿毒综合征患者的特征。
Rev Peru Med Exp Salud Publica. 2023 Apr-Jun;40(2):207-212. doi: 10.17843/rpmesp.2023.402.12708.
4
Recent Advances in the Management of Microangiopathic Hemolytic Anemias (MAHA): A Narrative Review.微血管病性溶血性贫血(MAHA)管理的最新进展:一项叙述性综述
Cureus. 2023 Oct 17;15(10):e47196. doi: 10.7759/cureus.47196. eCollection 2023 Oct.
5
Factors affecting dialysis duration in children with Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome.产志贺毒素大肠杆菌相关性溶血尿毒综合征患儿透析时间的影响因素。
Pediatr Nephrol. 2023 Aug;38(8):2753-2761. doi: 10.1007/s00467-022-05839-0. Epub 2023 Jan 27.